Stock Track | Biostar Pharmaceuticals Soars 30% Following Successful $16 IPO Pricing

Stock Track

2024-10-31

Shares of Beijing Biostar Pharmaceuticals Co Ltd surged 30% on Wednesday, the first trading day after the company announced the final offer price of HK$16.00 (approx. $2.04) per share in its global initial public offering (IPO).

The significant stock price increase reflects strong investor demand for the Chinese biopharmaceutical firm's shares. Biostar Pharmaceuticals raised around $344 million in the Hong Kong IPO, according to Reuters calculations based on the final pricing.

Founded in 2020, Biostar Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for metabolic diseases, oncology, and other areas with high unmet medical needs. The company plans to use the IPO proceeds to fund clinical trials, research and development activities, and potential commercialization of its drug candidates.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1146934064"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1146934064\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1146934064?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-31 09:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146934064","market":"us","top_or_hot":-1,"title":"Stock Track | Biostar Pharmaceuticals Soars 30% Following Successful $16 IPO Pricing","media":"Stock Track","content":"<p>Shares of Beijing Biostar Pharmaceuticals Co Ltd surged 30% on Wednesday, the first trading day after the company announced the final offer price of HK$16.00 (approx. $2.04) per share in its global initial public offering (IPO).</p>\n\n<p>The significant stock price increase reflects strong investor demand for the Chinese biopharmaceutical firm's shares. Biostar Pharmaceuticals raised around $344 million in the Hong Kong IPO, according to Reuters calculations based on the final pricing.</p>\n\n<p>Founded in 2020, Biostar Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for metabolic diseases, oncology, and other areas with high unmet medical needs. The company plans to use the IPO proceeds to fund clinical trials, research and development activities, and potential commercialization of its drug candidates.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Biostar Pharmaceuticals Soars 30% Following Successful $16 IPO Pricing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Biostar Pharmaceuticals Soars 30% Following Successful $16 IPO Pricing\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2024-10-31 09:33</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shares of Beijing Biostar Pharmaceuticals Co Ltd surged 30% on Wednesday, the first trading day after the company announced the final offer price of HK$16.00 (approx. $2.04) per share in its global initial public offering (IPO).</p>\n\n<p>The significant stock price increase reflects strong investor demand for the Chinese biopharmaceutical firm's shares. Biostar Pharmaceuticals raised around $344 million in the Hong Kong IPO, according to Reuters calculations based on the final pricing.</p>\n\n<p>Founded in 2020, Biostar Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for metabolic diseases, oncology, and other areas with high unmet medical needs. The company plans to use the IPO proceeds to fund clinical trials, research and development activities, and potential commercialization of its drug candidates.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02563","symbol_name":"華昊中天醫藥-B","start_time":0,"source_url":"","article_id":"1146934064","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146934064","pubTimestamp":1730338404,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Beijing Biostar Pharmaceuticals Co Ltd surged 30% on Wednesday, the first trading day after the company announced the final offer price of HK$16.00  per share in its global initial public offering .The significant stock price increase reflects strong investor demand for the Chinese biopharmaceutical firm's shares. Biostar Pharmaceuticals raised around $344 million in the Hong Kong IPO, according to Reuters calculations based on the final pricing.Founded in 2020, Biostar Pharmaceuticals","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02563":"华昊中天医药-B"},"translate_title":"Biostar Pharmaceuticals成功IPO定价16美元后股价飙升30%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02563":1},"content_text":"Shares of Beijing Biostar Pharmaceuticals Co Ltd surged 30% on Wednesday, the first trading day after the company announced the final offer price of HK$16.00 (approx. $2.04) per share in its global initial public offering (IPO).\nThe significant stock price increase reflects strong investor demand for the Chinese biopharmaceutical firm's shares. Biostar Pharmaceuticals raised around $344 million in the Hong Kong IPO, according to Reuters calculations based on the final pricing.\nFounded in 2020, Biostar Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for metabolic diseases, oncology, and other areas with high unmet medical needs. The company plans to use the IPO proceeds to fund clinical trials, research and development activities, and potential commercialization of its drug candidates.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}